Race for Merck Pill Raises Fears of Vaccine-Like Inequality (2)

Oct. 12, 2021, 6:04 PM

Moves by several countries to buy supplies of Merck & Co.’s promising Covid pill before it’s even approved are raising concerns that some poorer nations could be left behind, in a repeat of the slow and inequitable rollout of vaccines.

Merck has taken steps to ensure countries around the world can get its drug, including licensing its experimental medication to generic-drug firms and planning production increases. Yet in a worrisome echo of the global vaccine situation, some wealthy and middle-income nations like Australia, Singapore, Malaysia and Thailand have followed the U.S. and already secured molnupiravir or started talks to ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.